Pradaxa Should Not be Used in Patients Mechanical Heart Valves: FDA

by Kathy Jones on  December 21, 2012 at 7:27 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has issued a warning over blood thinner Pradaxa, stating that the drug should not be used in patients mechanical heart valves.
 Pradaxa Should Not be Used in Patients Mechanical Heart Valves: FDA
Pradaxa Should Not be Used in Patients Mechanical Heart Valves: FDA

Pradaxa is one of the more popular drugs used in preventing strokes or blood clots in heart patients but a large scale study in Europe, known as RE-ALIGN, was stopped after researchers found that the drug instead increased the risk of strokes and blood clots in patients fitted with mechanical heart valves.

The FDA recommended that patients who are currently taking Pradaxa, also known as dabigatran, should visit their doctors before switching to a different anticoagulant as they could face other problems if they suddenly stopped taking the drug on their own.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive